Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Jason Slakter, MD Appointed Chief Medical Officer Glenn L. Stoller, MD Appointed Chief Scientific Officer Peter K. Kaiser, MD Appointed as Senior Vice President of Product Development NEW...
-
Transaction Expands Ohr's Pipeline to Include Multiple New Drug Candidates in Ophthalmology Provides Ohr with Proprietary Sustained Release Drug Delivery Platform for Ocular Drugs Upfront...
-
MELVILLE, NY--(Marketwired - May 15, 2014) - The Long Island Capital Alliance ("LICA"), the leading non-profit capital formation and business development organization serving regional companies,...
-
NEW YORK, May 9, 2014 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq:OHRP), a research and development company with a primary focus in ophthalmology, today announced the initiation of a Phase II...
-
SAN FRANCISCO, CA--(Marketwired - May 2, 2014) - Vista Partners ("Vista") published its FREE Macroeconomic & Investment Monthly Newsletter for the month of May. Each monthly newsletter from...
-
MELVILLE, NY--(Marketwired - May 1, 2014) - The Long Island Capital Alliance ("LICA"), the leading non-profit capital formation and business development organization serving regional companies,...
-
NEW YORK, April 29, 2014 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq:OHRP), a pharmaceutical company focused on the development of novel therapeutics for large unmet medical needs, today...
-
NEW YORK, April 8, 2014 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq:OHRP), a pharmaceutical company focused on the development of novel therapeutics for large unmet medical needs, today...
-
NEW YORK, March 10, 2014 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical (Nasdaq:OHRP), a pharmaceutical company focused on the development of novel therapeutics for large unmet medical needs, today announced...
-
SAN FRANCISCO, CA--(Marketwired - Mar 7, 2014) - Vista Partners ("Vista") announced today that it published its FREE Macroeconomic & Investment Monthly Newsletter for the month of March. Each...